surgiGRAFT Product Attributes
The surgiGRAFT suite of products includes amniotic tissue derived allografts intended for reconstruction, repair, or replacement of a patient’s tissue.
Chorion free and orientation neutral Hydrated Form: hydrophilic properties allow tissue to conform to the surface or surgical site
Dry Form: handling properties allow easy application for open surgical techniques
Ambient temperature storage: terminally sterilized with up to a 3-year shelf life
Flexible: naturally conforms to complex anatomies
Fully resorbable: may be applied directly over bone, tendon, nerves, and wounds
Available in a range of sizes for optimal coverage.
For reimbursement support, please email reimbursement@synergybiologics.net
Amniotic Tissue Allografts are regulated under the FDA’s Public Health Service Act Section 361 as a Human Cell, Tissue or Cellular or Tissue Based Product (HCTP).
Handled according to all FDA regulations for Current Good Tissue Practices, its manipulation and processing are kept to a minimum, ensuring the preservation of its innate properties that help to promote advanced healing.
FDA Tissue Standards
